Ceapro Inc
XTSX:CZO

Watchlist Manager
Ceapro Inc Logo
Ceapro Inc
XTSX:CZO
Watchlist
Price: 5.99 CAD 0.5% Market Closed
Market Cap: 18.3m CAD
Have any thoughts about
Ceapro Inc?
Write Note

Ceapro Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ceapro Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Ceapro Inc
XTSX:CZO
Net Issuance of Common Stock
CA$16.9k
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Burcon NutraScience Corp
TSX:BU
Net Issuance of Common Stock
CA$4.5m
CAGR 3-Years
-1%
CAGR 5-Years
-22%
CAGR 10-Years
-2%
EcoSynthetix Inc
TSX:ECO
Net Issuance of Common Stock
-$1.3m
CAGR 3-Years
-78%
CAGR 5-Years
13%
CAGR 10-Years
-11%
5N Plus Inc
TSX:VNP
Net Issuance of Common Stock
$685k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
13%
Neo Performance Materials Inc
TSX:NEO
Net Issuance of Common Stock
-$5.5m
CAGR 3-Years
-72%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Ceapro Inc
Glance View

Market Cap
18.3m CAD
Industry
Chemicals

Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.

CZO Intrinsic Value
7.9 CAD
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Ceapro Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
16.9k CAD

Based on the financial report for Dec 31, 2023, Ceapro Inc's Net Issuance of Common Stock amounts to 16.9k CAD.

What is Ceapro Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
51%

Over the last year, the Net Issuance of Common Stock growth was -79%. The average annual Net Issuance of Common Stock growth rates for Ceapro Inc have been 51% over the past three years .

Back to Top